期刊文献+

FXR与糖尿病相关性研究进展 被引量:3

Relationship between FXR and Diabetes Research Progress
原文传递
导出
摘要 国际糖尿病联盟(IDF)最新数据表明目前中国糖尿病患者在剧增。糖尿病是以胰岛素分泌相对或和绝对不足导致的慢性高血糖为特征的代谢性疾病,法尼醇X受体(farnesoid X receptor,FXR,NR1H4)是能被胆汁酸激活的转录因子,FXR能对胆汁酸的代谢进行调节,胆汁酸代谢与糖尿病相关,胆汁酸代谢在β细胞的功能是通过FXR介导的,本文回顾国内外有关法尼醇X受体通过抑制肝糖原异生、增加肝糖原储存、影响胰岛素信号、增加胰岛素的分泌和增强胰岛素的敏感性等机制发挥调节血糖平衡作用的研究,意在探索FXR与糖尿病的相关性,为糖尿病的发病机制提供新的理论依据。 The international diabetes federation (IDF)'s latest data showed that Chinese patients with diabetes are in the surge. Diabetes is caused by insulin secretion insufficient and absolute characterized by chronic high blood sugar metabolic disease. FXR are bile acid activation, transcription factors,and can adjust zhe bile acid metabolism, nevertheless, Bile acid metabolism associated with diabetes, Bile acid metabolism in B-cell function is mediated by FXR, farnesoid X receptor plays a role of regulating blood sugar balance by inhibiting liver glycogen dysplasia, increasing liver glycogen storage, affecting of insulin signal, increasing insulin secretion, enhancing insulin sensitivity and other mechanisms. To explore the correlation between FX and diabetes, providing new theoretical basis for the Dathogenesis of diabetes.
出处 《现代生物医学进展》 CAS 2015年第26期5197-5200,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81260135)
关键词 法尼醇X受体 FXR 糖尿病 糖代谢 Farnesoid X receptor FXR Diabetes mellitus Glycometabolism
  • 相关文献

参考文献2

二级参考文献43

  • 1Fiorucci S, Mencarelli A, Palladino G, et al. Bile-acid-activated re- ceptors:targeting TGR5 and farnesoid-X-receptor in lipid and glu- cose disorders[ J]. Trends Pharmacol Sci,2009,30( 11 ) :570-580.
  • 2Zhang S, Wang J, Liu Q, et al. Farnesoid X receptor agonist WAY- 362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis[ J]. J Itepatol,2009,51 (2) :380-388.
  • 3Wang XX, Jiang T, Shen Y, et al. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria [ J ]. Am J Physiol Renal Physiol, 2009,297 ( 6 ) : F1587-1596.
  • 4Schwartz YSh, Khoshchenko OM, Dushkin MI, et al. Effects of cho- lesterol and nuclear hormone receptor agonists on the production of transforming growth factor-beta in macrophages [ J ]. Bull Exp Biol Med ,2009,148 (3) :406-409.
  • 5Shankland S J, Scholey JW, Ly H et al. Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy [ J ]. Kidney Int,1994,46(2) :4243.
  • 6aAustin H, Muenz L, Jnyce KM, et al. Diffues proliferati'e lupus ne- phritis:identification of specific pathologic features affecting renal outcome [ J ]. Kidney Int, 1984,25 : 689-695.
  • 7Zhao-Long Wu, Nian-Song Wang, Xun-Hui Xu, eta|. Positive and negative hepatitis B virus in renal biopsies of IgA nephropathy: an 85-case clinicopathological analysis [ J ]. Nephrology, 2001,6 ( 4 ) : 185-189.
  • 8Jiang T, Wang XX, Scherzer P, et al. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy [ J ]. Diabe- tes,2007,56 ( 10 ) : 2485-2493.
  • 9Inge AM, van den Oever. Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus [ A ]. Mediators of Inflammation, 2010,Article ID 792393 : 15.
  • 10Ronald B. Cytokine and Cytokine-Like Inflammation Markers, Endo- thelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications[ J. J Clin Endocrinol Metab ,2009, 94(9) :3171-3182.

共引文献6

同被引文献19

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部